Xvivo Perfusion — Director's Dealing 2021

Nov 1, 2021

Issuer Xvivo Perfusion Aktiebolag

Holder

Bure Equity AB

Instrument

Instrument	AK SE0004840718
Before the transaction
Shares	4,322,504
Voting rights	4,322,504
Transaction
Date	28/10/2021
Limit for number of shares 15 %
Limit for number of votes	15 %
After the transaction
Quantity
Shares	4,367,504

Percentage
Indirectly held voting rights 0
Directly held voting rights 4,367,504

Directly held shares	14.8 %
Directly held voting rights 14.8 %
Indirectly held voting rights 0 %

Resulting distribution of total

holdings
	Percentage of voting rights:	Number of underlying shares:
Shares	14.8 %	4,367,504
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	14.8 %	4,367,504
Group total holdings
Voting rights 4,367,504
Percentage of voting rights 14.8
Notes (other relevant informations according to law)

Xvivo Perfusion genomförde en riktad nyemission den 28 oktober 2021. Bure förvärvade 45 000 aktier. Bures ägarandel uppgår till 14,8 procent efter transaktionen.

Published

01/11/2021 11:27

Contact

Name Max Jonson Phone +46725087512 Email max.jonson@bure.se

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25